Brii said it agreed to purchase the assets from VBI Vaccines Inc. and its creditors for $18 million. The deal gives Brii full access to the remaining IP, patents and materials related to BRII-179, an ...

# A MAN was remanded into custody on Friday after he was accused of a triple shooting in the Big Pond area earlier this month that claimed the life of Rashad Sweeting, the year’s first murder victim. ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...

VBI Vaccines has trumpeted top-line data from a trial pitting its hepatitis B virus (HBV) vaccine candidate against GlaxoSmithKline’s Engerix-B – but investors weren’t convinced, and its ...

# Chief Magistrate Roberto Reckley arraigned Rayshene Lightbourne, 35, on attempted murder and possession of a firearm with intent to endanger life. # Lightbourne’s co-accused Kevin Pierre, 35, was ...

Chanson International operates bakeries in China and New York, with about 50 locations and under $20 million in annual ...

CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies ...

STORY HIGHLIGHTS Brii Biosciences acquires BRII-179 assets from VBI Vaccines. The $18 million deal cancels previous agreements and obligations. BRII-179 is in Phase 2 study as a hepatitis B treatment.

VBI Vaccines ( (VBIVQ) ) has shared an announcement.